{"Title": "Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (\u2265 9 log10 copies/ml)", "Year": 2015, "Source": "Liver Int.", "Volume": "35", "Issue": 2, "Art.No": null, "PageStart": 422, "PageEnd": 428, "CitedBy": 6, "DOI": "10.1111/liv.12694", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84921485509&origin=inward", "Abstract": "\u00a9 2014 John Wiley & Sons A/S.Background & Aims: We evaluated the antiviral response of Asian or Pacific Islander (API) patients with chronic hepatitis B (CHB) who had baseline high viral load (HVL), defined as pre-treatment hepatitis B virus (HBV) DNA \u22659 log10 copies/ml, following up to 288 weeks of tenofovir disoproxil fumarate (TDF) treatment. Methods: A total of 205 HBeAg-negative and HBeAg-positive self-described API patients received 48 weeks of TDF 300 mg (HVL n = 18) or adefovir dipivoxil 10 mg (HVL n = 15) in a blinded fashion, followed by open-label TDF for an additional 240 weeks. The proportions of HVL vs. non-HVL patients with HBV DNA <400 copies/ml were compared. Mean declines in HBV DNA were evaluated in API vs. non-API patients. Results: Throughout the first 72 weeks of treatment, a smaller proportion of HVL API patients reached HBV DNA <400 copies/ml than non-HVL API patients. However, after this timepoint similar proportions of HVL and non-HVL API patients achieved HBV DNA <400 copies/ml (100% vs. 97%, respectively), which was maintained through week 288, where 92% of HVL patients and 99% of non-HVL API patients on treatment had HBV DNA <400 copies/ml. During the 288 weeks of treatment, API patients had similar mean HBV DNA declines as non-API patients, regardless of whether patients were HVL or non-HVL. No API HVL patient had persistent viremia at week 288. No resistance was detected among HVL or non-HVL patients. Conclusions: API patients with HVL CHB achieve HBV DNA <400 copies/ml with long-term TDF treatment; however, achieving viral suppression may take longer for HVL patients relative to non-HVL API patients.", "AuthorKeywords": ["Asian", "Hepatitis B", "Tenofovir disoproxil fumarate", "Viremia"], "IndexKeywords": ["Adenine", "Adult", "Asian Continental Ancestry Group", "Drug Resistance, Viral", "Hepatitis B, Chronic", "Humans", "Oceanic Ancestry Group", "Organophosphonates", "Statistics, Nonparametric", "Viral Load"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84921485509", "SubjectAreas": [["Hepatology", "MEDI", "2721"]], "AuthorData": {"7201970083": {"Name": "Fung S.", "AuthorID": "7201970083", "AffiliationID": "60016849", "AffiliationName": "University of Toronto"}, "7401828663": {"Name": "Gordon S.C.", "AuthorID": "7401828663", "AffiliationID": "60030704", "AffiliationName": "Henry Ford Health System"}, "55401051000": {"Name": "Krastev Z.", "AuthorID": "55401051000", "AffiliationID": "100898925", "AffiliationName": "University Hospital"}, "57200769993": {"Name": "Horban A.", "AuthorID": "57200769993", "AffiliationID": "60069009", "AffiliationName": "Warsaw Medical University"}, "24370194200": {"Name": "Petersen J.", "AuthorID": "24370194200", "AffiliationID": "60022215", "AffiliationName": "Liver Unit Asklepios Klinik St. Georg"}, "6602711421": {"Name": "Sperl J.", "AuthorID": "6602711421", "AffiliationID": "60020529", "AffiliationName": "Institute for Clinical and Experimental Medicine"}, "7003720102": {"Name": "Gane E.", "AuthorID": "7003720102", "AffiliationID": "60011750", "AffiliationName": "Auckland City Hospital"}, "35353434500": {"Name": "Jacobson I.M.", "AuthorID": "35353434500", "AffiliationID": "60007997", "AffiliationName": "Weill Cornell Medical College"}, "7005066161": {"Name": "Yee L.J.", "AuthorID": "7005066161", "AffiliationID": "60002909", "AffiliationName": "Gilead Sciences Inc."}, "55343249300": {"Name": "Dinh P.", "AuthorID": "55343249300", "AffiliationID": "60002909", "AffiliationName": "Gilead Sciences Inc."}, "7103315124": {"Name": "Martins E.B.", "AuthorID": "7103315124", "AffiliationID": "60002909", "AffiliationName": "Gilead Sciences Inc."}, "7102825519": {"Name": "Flaherty J.F.", "AuthorID": "7102825519", "AffiliationID": "60002909", "AffiliationName": "Gilead Sciences Inc."}, "8784133500": {"Name": "Kitrinos K.M.", "AuthorID": "8784133500", "AffiliationID": "60002909", "AffiliationName": "Gilead Sciences Inc."}, "7006885162": {"Name": "Dusheiko G.", "AuthorID": "7006885162", "AffiliationID": "60032819", "AffiliationName": "Royal Free Hospital"}, "7005816675": {"Name": "Trinh H.", "AuthorID": "7005816675", "AffiliationID": "100314967", "AffiliationName": "San Jose Gastroenterology"}, "55163745800": {"Name": "Flisiak R.", "AuthorID": "55163745800", "AffiliationID": "60026724", "AffiliationName": "Medical University of Bialystok"}, "7003299298": {"Name": "Rustgi V.K.", "AuthorID": "7003299298", "AffiliationID": "100556099", "AffiliationName": "Metropolitan Liver Diseases"}, "7007153523": {"Name": "Buti M.", "AuthorID": "7007153523", "AffiliationID": "60012486, 60078879", "AffiliationName": "Hospital General Universitari Vall d'Hebron and Ciberehd del Instituto Carlos III"}, "7102079502": {"Name": "Marcellin P.", "AuthorID": "7102079502", "AffiliationID": "60005915", "AffiliationName": "H\u00f4pital Beaujon, University of Paris"}}}